Trial failure forces Xenova cutbacks

October 28, 2003
Research and Development

Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about …

Six-month delay could be fatal for GP contract

October 28, 2003

The crisis surrounding the proposed new GP contract has deepened after doctors refused to be "stampeded" into accepting a new …

Hassan hits the ground running on Schering-Plough re-organisation

October 28, 2003
Sales and Marketing

Fred Hassan has announced a major re-organisation of Schering-Plough's pharmaceutical operations just 17 days after taking on the job of …

UK’s pharmaceutical profit control scheme to be reviewed

October 28, 2003
Sales and Marketing

The agreement between the UK government and the pharmaceutical industry which controls company profits is to be reviewed.Introduced in 1999, …

Roche launches first proactive patient helpline

October 28, 2003
Medical Communications, Sales and Marketing

Roche and health call-centre specialists International SOS have launched the UK's first ever helpline to proactively support patients to keep …

Private sector invited to run NHS surgery centres

October 28, 2003

Private sector companies have been invited to run the latest wave of new diagnostic treatment centres (DTC) to help cut …

European HRT safety probe launched

October 28, 2003
Sales and Marketing

The European Union medicines regulator is to investigate the safety of hormone replacement therapy products following a new study was …

UK research centre falls victim to Pfizer merger

October 28, 2003
Research and Development

A leading UK drug discovery centre is one of a number of global sites to close following Pfizer's recently completed …

Roche’s targeted cancer drug fails

October 28, 2003
Research and Development

A new type of cancer drug developed by Roche, Genentech and OSI Pharmaceuticals has failed to prove its efficacy in …

Rebels fail to halt foundation trust plans

October 28, 2003

The Government has won a crucial House of Commons vote in favour of its plans to allow top-performing hospitals to …

New data boosts AstraZeneca’s Atacand

October 28, 2003
Research and Development, Sales and Marketing

New trial data on AstraZeneca's blood pressure treatment Atacand could give the drug a lead over rivals in the same …

The Gateway to Local Adoption Series

Latest content